当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析

云南白药

(000538)

  

流通市值:1001.22亿  总市值:1007.75亿
流通股本:17.73亿   总股本:17.84亿

云南白药(000538)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润19.28亿元,每股收益1.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益4079496.92万元,未分配利润1891597.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产5425302.63万元,负债1345805.72万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入10,841,237,721.2940,033,300,814.7229,915,155,069.8420,455,286,287.52
营业总成本8,751,171,876.2635,206,797,286.525,480,753,830.7817,225,017,022.4
营业利润2,255,305,450.435,711,621,822.285,010,889,055.013,672,352,263.88
利润总额2,255,981,3955,684,719,663.995,013,251,270.613,672,028,340.83
净利润1,927,511,203.494,767,072,360.284,329,700,490.033,189,962,850.96
其他综合收益-122,538.7-13,441,329.34-5,079,332.38-8,020,440.18
综合收益总额1,927,388,664.794,753,631,030.944,324,621,157.653,181,942,410.78
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计35,436,604,060.534,150,663,141.0837,400,015,187.5236,434,121,741.84
非流动资产合计18,816,422,257.1418,763,518,191.9718,212,503,942.6617,933,423,490.4
资产总计54,253,026,317.6452,914,181,333.0555,612,519,130.1854,367,545,232.24
流动负债合计12,240,342,494.1812,858,491,395.2413,903,888,177.7613,797,971,436.66
非流动负债合计1,217,714,657.531,189,605,375.541,165,244,401.551,179,406,015.03
负债合计13,458,057,151.7114,048,096,770.7815,069,132,579.3114,977,377,451.69
归属于母公司股东权益合计40,768,110,417.8738,831,946,424.5140,522,380,082.7739,369,278,205.03
股东权益合计40,794,969,165.9338,866,084,562.2740,543,386,550.8739,390,167,780.55
负债和股东权益合计54,253,026,317.6452,914,181,333.0555,612,519,130.1854,367,545,232.24
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计10,830,762,784.1643,880,006,829.3732,872,412,099.3722,451,954,609.95
经营活动现金流出小计10,117,165,224.5139,583,003,687.128,799,273,354.0319,190,337,217.96
经营活动产生的现金流量净额713,597,559.654,297,003,142.274,073,138,745.343,261,617,391.99
投资活动现金流入小计946,127,434.078,019,213,440.175,125,866,466.373,879,646,690.27
投资活动现金流出小计1,012,765,741.899,218,214,486.646,283,661,079.584,085,229,378.59
投资活动产生的现金流量净额-66,638,307.82-1,199,001,046.47-1,157,794,613.21-205,582,688.32
筹资活动现金流入小计16,000,439.391,962,072,461.451,538,345,214.751,527,305,554.25
筹资活动现金流出小计487,209,760.468,939,807,625.335,200,040,692.264,672,820,483.22
筹资活动产生的现金流量净额-471,209,321.07-6,977,735,163.88-3,661,695,477.51-3,145,514,928.97
汇率变动对现金及现金等价物的影响1,032,499.263,497,174.93-2,606,865.09-48,577.76
现金及现金等价物净增加额176,782,430.02-3,876,235,893.15-748,958,210.47-89,528,803.06
期末现金及现金等价物余额10,452,312,005.3610,275,529,575.3413,402,807,258.0214,062,236,665.43
最新报告期:2025-05-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投袁全,刘若飞,贺菊颖2.873.153.482025-05-21
招商证券梁广楷,欧阳京,许菲菲2.893.163.452025-05-12
中信建投袁全,刘若飞,贺菊颖2.873.153.482025-05-08
华泰证券代雯,唐庆雷,张云逸2.953.273.612025-04-30
中金公司张琎,朱言音,杨一正2.933.22--2025-04-30
TOP↑